DK0831790T3 - Fremgangsmåder til stabil inkorporering af stoffer i tørre opskummede glasmatricer og derved opnåede sammensætninger - Google Patents

Fremgangsmåder til stabil inkorporering af stoffer i tørre opskummede glasmatricer og derved opnåede sammensætninger

Info

Publication number
DK0831790T3
DK0831790T3 DK96917569T DK96917569T DK0831790T3 DK 0831790 T3 DK0831790 T3 DK 0831790T3 DK 96917569 T DK96917569 T DK 96917569T DK 96917569 T DK96917569 T DK 96917569T DK 0831790 T3 DK0831790 T3 DK 0831790T3
Authority
DK
Denmark
Prior art keywords
methods
compositions obtained
foamed glass
stably incorporating
dry foamed
Prior art date
Application number
DK96917569T
Other languages
Danish (da)
English (en)
Inventor
Enda Martin Gribbon
Bruce Joseph Roser
Original Assignee
Elan Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23930384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0831790(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elan Drug Delivery Ltd filed Critical Elan Drug Delivery Ltd
Application granted granted Critical
Publication of DK0831790T3 publication Critical patent/DK0831790T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96917569T 1995-06-07 1996-06-07 Fremgangsmåder til stabil inkorporering af stoffer i tørre opskummede glasmatricer og derved opnåede sammensætninger DK0831790T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48604395A 1995-06-07 1995-06-07
PCT/GB1996/001367 WO1996040077A2 (en) 1995-06-07 1996-06-07 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby

Publications (1)

Publication Number Publication Date
DK0831790T3 true DK0831790T3 (da) 2003-09-01

Family

ID=23930384

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96917569T DK0831790T3 (da) 1995-06-07 1996-06-07 Fremgangsmåder til stabil inkorporering af stoffer i tørre opskummede glasmatricer og derved opnåede sammensætninger

Country Status (22)

Country Link
EP (1) EP0831790B1 (hu)
JP (1) JP4502406B2 (hu)
KR (1) KR19990022710A (hu)
CN (1) CN1245957C (hu)
AP (1) AP852A (hu)
AT (1) ATE239451T1 (hu)
AU (1) AU713599B2 (hu)
BR (1) BR9609188A (hu)
CA (1) CA2223438C (hu)
CZ (1) CZ391297A3 (hu)
DE (1) DE69628007T2 (hu)
DK (1) DK0831790T3 (hu)
ES (1) ES2194992T3 (hu)
HU (1) HUP9901716A3 (hu)
IL (1) IL122482A (hu)
MX (1) MX9709716A (hu)
NO (1) NO975773L (hu)
NZ (1) NZ309841A (hu)
PL (1) PL184823B1 (hu)
PT (1) PT831790E (hu)
SK (1) SK167597A3 (hu)
WO (1) WO1996040077A2 (hu)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0762897B1 (en) 1994-06-02 2003-04-02 Elan Drug Delivery Limited Method of preventing aggregation of proteins/peptides upon rehydration or thawing
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
EP1032647B1 (en) * 1997-11-26 2006-03-29 Universal Preservation Technologies, Inc. Preservation of sensitive biological samples by vitrification
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
AU2945199A (en) * 1998-03-18 1999-10-11 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6306345B1 (en) 1998-05-06 2001-10-23 Universal Preservation Technologies, Inc. Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
GB9904049D0 (en) * 1999-02-22 1999-04-14 Quadrant Holdings Cambridge Rapidly-soluble compositions
JP2011025068A (ja) * 1999-02-22 2011-02-10 Chugai Pharmaceut Co Ltd プレフィルドシリンジタンパク質溶液製剤
ATE366797T1 (de) * 1999-05-04 2007-08-15 Anhydro Ltd Verfharen zur konservierung von viren und mycoplasma
US6692695B1 (en) 1999-05-06 2004-02-17 Quadrant Drug Delivery Limited Industrial scale barrier technology for preservation of sensitive biological materials
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
CA2382061A1 (en) * 1999-08-19 2001-02-22 Victor Bronshtein Preservation of bacterial cells at ambient temperatures
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CN1236764C (zh) * 2000-06-27 2006-01-18 霍夫曼-拉罗奇有限公司 制备组合物的方法
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US6537666B1 (en) 2000-10-23 2003-03-25 Universal Preservation Technologies, Inc. Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
JP2005508992A (ja) * 2001-11-09 2005-04-07 セントカー・インコーポレーテツド 凍結乾燥されたモノクローナル抗体組成物
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
MXPA05004528A (es) * 2002-11-01 2005-07-26 Glaxosmithkline Biolog Sa Composicion inmunogenica.
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
GB0409795D0 (en) * 2004-04-30 2004-06-09 Glaxosmithkline Biolog Sa Drying method
DE602005016402D1 (de) * 2004-05-24 2009-10-15 Genvault Corp Stabile lagerung von protein und stabile lagerung von nukleinsäure in wiedergewinnbarer form
WO2005117962A1 (en) 2004-06-02 2005-12-15 Victor Bronshtein Preservation by vaporization
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
WO2009012601A1 (en) * 2007-07-26 2009-01-29 Sanofi Pasteur Limited Antigen-adjuvant compositions and methods
EP2334792B1 (en) 2008-09-12 2020-09-09 GenTegra LLC Matrices and media for storage and stabilization of biomolecules
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
ES2643148T3 (es) 2009-05-26 2017-11-21 Advanced Bionutrition Corporation Composición en polvo seco estable que comprende microorganismos biológicamente activos y/o materiales bioactivos y métodos de producción
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN102725393B (zh) 2010-01-28 2015-12-02 先进生物营养公司 包含生物活性材料的干燥玻璃质组合物
WO2012021783A2 (en) * 2010-08-13 2012-02-16 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
US20120219590A1 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
WO2012158978A1 (en) * 2011-05-17 2012-11-22 Soligenix, Inc. Thermostable vaccine compositions and methods of preparing same
PE20191242A1 (es) 2011-10-25 2019-09-16 Prothena Biosciences Ltd Formulaciones de anticuerpo y metodos
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
EP3328215B1 (en) 2015-07-29 2021-07-07 Advanced BioNutrition Corp. Stable dry probiotic compositions for special dietary uses
FI4035762T3 (fi) * 2015-09-09 2023-12-04 Drawbridge Health Inc Laitteita näytteiden keräämistä, stabilointia ja säilytystä varten
CN106434840B (zh) * 2016-12-02 2019-08-09 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
CN106591415B (zh) * 2017-01-03 2019-12-10 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
CN106676161B (zh) * 2017-01-03 2020-01-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
CN106701887B (zh) * 2017-01-03 2020-01-17 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
CN106676160B (zh) * 2017-01-03 2020-02-21 北京中检葆泰生物技术有限公司 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
AU2018207302B2 (en) 2017-01-10 2023-07-13 Drawbridge Health, Inc. Devices, systems, and methods for sample collection
CN117050969B (zh) * 2023-08-18 2024-04-02 北京中检葆泰生物技术有限公司 一种碱性磷酸酶的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362830A (en) * 1966-04-04 1968-01-09 American Mach & Foundry Preparation of water soluble product
JPS57100177A (en) * 1980-12-16 1982-06-22 Showa Denko Kk Mixed agent composition of amino acid with saccharide
CA1258428A (en) * 1984-06-28 1989-08-15 Nalinkant C. Damani Antacid composition
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
CA2031191C (en) * 1989-05-01 1997-03-25 Julian P. Breillatt, Jr. Composition of beneficial agent and method for administering the same by controlled dissolution
DE3918051A1 (de) * 1989-06-02 1990-12-06 Haensel Otto Gmbh Verfahren zur satzweisen herstellung einer beluefteten suesswarenschaummasse aus einer zuckerloesung und einer aufschlagmittelloesung
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
JPH06182189A (ja) * 1991-05-31 1994-07-05 Res Corp Technol Inc 自己乳化型ガラス
JP3164854B2 (ja) * 1991-10-31 2001-05-14 雪印乳業株式会社 皮膚衛生用シート
WO1993010758A1 (en) * 1991-12-05 1993-06-10 Pitman-Moore, Inc. A carbohydrate glass matrix for the sustained release of a therapeutic agent
JP2640570B2 (ja) * 1992-01-13 1997-08-13 ファイザー インク． 強度が増加した錠剤の製造
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica

Also Published As

Publication number Publication date
IL122482A (en) 1999-10-28
CZ391297A3 (cs) 1998-05-13
NO975773L (no) 1998-02-03
CN1193908A (zh) 1998-09-23
PT831790E (pt) 2003-07-31
CN1245957C (zh) 2006-03-22
NO975773D0 (no) 1997-12-08
KR19990022710A (ko) 1999-03-25
AP852A (en) 2000-06-16
JPH11506467A (ja) 1999-06-08
AU713599B2 (en) 1999-12-09
ATE239451T1 (de) 2003-05-15
HUP9901716A2 (hu) 1999-09-28
WO1996040077A2 (en) 1996-12-19
EP0831790B1 (en) 2003-05-07
JP4502406B2 (ja) 2010-07-14
EP0831790A2 (en) 1998-04-01
WO1996040077A3 (en) 1997-01-23
CA2223438A1 (en) 1996-12-19
NZ309841A (en) 1999-10-28
AU6009896A (en) 1996-12-30
BR9609188A (pt) 1999-05-11
DE69628007D1 (de) 2003-06-12
SK167597A3 (en) 1998-10-07
MX9709716A (es) 1998-03-31
CA2223438C (en) 2008-05-13
DE69628007T2 (de) 2003-11-27
ES2194992T3 (es) 2003-12-01
PL323902A1 (en) 1998-04-27
AP9701151A0 (en) 1998-01-31
PL184823B1 (pl) 2002-12-31
IL122482A0 (en) 1998-06-15
HUP9901716A3 (en) 2000-04-28

Similar Documents

Publication Publication Date Title
DK0831790T3 (da) Fremgangsmåder til stabil inkorporering af stoffer i tørre opskummede glasmatricer og derved opnåede sammensætninger
DK0938517T3 (da) Stabil, opskummet fugemasse- og forseglingssammensætninger og fremgangsmåder til anvendelse deraf
NO990158L (no) Konservering ved skumdannelse
AU7378798A (en) Solid porous matrices and methods of making and using the same
IS3433A7 (is) Efni afleidd af pyrról og aðferð til framleiðslu þeirra
DK0979034T3 (da) Præparat til bekæmpelse af skadelige bioorganismer og fremgangsmåde til bekæmpelse af skadelige bioorganismer ved anvendelse af dette
DK0920491T3 (da) Immortaliserede cellelinier til virusvækst
NO992803D0 (no) Substansblandinger inneholdende stabiliseringsmidler og sammensetninger inneholdende vinylgrupper
DE69536105D1 (de) Massenspektrometer
ATE219328T1 (de) Fungizide mischung
DE69636411D1 (de) Abstimmbarer verstärker
DE69700863D1 (de) Glaszusammensetzung
DK0939749T3 (da) Fremgangsmåde til fremstilling af benzylethere
DK0926952T3 (da) Antimikrobiel sammensætning og fremgangsmåde til fremstilling deraf
DE69623728D1 (de) Massenspektrometer
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
DE69703434D1 (de) Form zusammensetzung enthaltend syndiotaktisches vinylaromat-polymer
DE59712835D1 (de) Stabilisierte monomerenzusammensetzung
DE69815835D1 (de) Schäumbare polymerzusammensetzung
NO995308L (no) Sammensetning og fremgangsmåter som anvender en eutomer
DK0941100T3 (da) Farmaceutiske præparater indeholdende lamivudin og zidovudin
GB9420644D0 (en) Non-linear styrenic polymer-based foams
IT1305315B1 (it) Derivati di politriazine contenenti gruppipolialchilpiperidinilossilici oppure gruppi
DK0914133T3 (da) Anvendelse af hyaluronan (HA) til cellemobilisering
NO973408L (no) Fremgangsmåte til fremstilling av alkyl-tert.butyletere og di-n-buten fra feltbutaner